Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Golden Predator Completes $9.3 Million Private Placement
-
Halozyme To Participate In 39th Annual Canaccord Genuity Growth Conference
-
Tesla (TSLA) PT Lowered to $350 at Canaccord Genuity
-
ServiceNow (NOW) PT Raised to $315 at Canaccord Genuity
-
LeMaitre Vascular (LMAT) PT Raised to $29 at Canaccord Genuity
-
iRobot Corporation (IRBT) PT Lowered to $75 at Canaccord Genuity
-
Facebook (FB) PT Raised to $240 at Canaccord Genuity
-
Cerner (CERN) PT Raised to $80 at Canaccord Genuity
-
Form 8.3 - [Accesso Technology Group plc (for CGWL)]
-
Livongo Health, Inc. (LVGO) Prices 12.687M Share IPO at $28/Sh
-
Castle Biosciences Inc. (CSTL) Prices 4M Share IPO at $16/Sh
-
Net Asset Value(s)
-
Castle Biosciences Announces Pricing of Initial Public Offering
-
Livongo Announces Pricing of Initial Public Offering
-
Livongo Announces Pricing of Initial Public Offering
-
POSaBIT Announces Updated Brokered Private Placement
-
Astronics Corporation to Present at Canaccord Genuity Global Growth Conference
-
Chembio Diagnostics to Participate in the Canaccord Genuity Growth Conference
-
iRhythm Technologies to Present at the 39th Annual Canaccord Genuity Global Growth Conference
-
Insulet to Present at Upcoming Investor Conferences
-
Strategic Metals Ltd. Closes Fully Subscribed Private Placement
-
Canaccord Genuity Downgrades Thomson Reuters (TRI) to Sell
-
ORBCOMM CEO to Present at the Canaccord Genuity 39th Annual Growth Conference
-
ORBCOMM CEO to Present at the Canaccord Genuity 39th Annual Growth Conference
-
Rezolute Completes $45 Million Investment Round with Full Exercise of $20 Million Option
-
Rezolute Completes $45 Million Investment Round with Full Exercise of $20 Million Option
-
Arcimoto President and Founder Mark Frohnmayer to Address Canaccord Genuity Future of Transport Conference on August 6
-
Digi International to Present at Canaccord Genuity Growth Conference
-
CalAmp To Present at the Canaccord Genuity Growth Conference on August 7
-
X4 Pharmaceuticals to Attend Two Upcoming Investor Conferences
-
Telaria To Present at the Canaccord Genuity 39th Annual Growth Conference
-
STRATA Skin Sciences to Participate in Canaccord Genuity 39th Annual Growth Conference
-
Shockwave Medical to Participate in the 39th Annual Canaccord Genuity Global Growth Conference
-
Shockwave Medical to Participate in the 39th Annual Canaccord Genuity Global Growth Conference
-
AngioDynamics to Present at the Canaccord Genuity Growth Conference
-
Canaccord Genuity Group Inc. Access to First Quarter Fiscal 2020 Results Information
-
PlacementTracker Publishes Q2 2019 PIPE and Private Placement Markets League Tables
-
KULR Technology Group To Attend Canaccord Genuity Investor Conferences In August 2019
-
KULR Technology Group To Attend Canaccord Genuity Investor Conferences In August 2019
-
IPG Photonics to Participate in Upcoming Investor Conferences
-
SolarEdge Technologies (SEDG) PT Raised to $68 at Canaccord Genuity
-
BioXcel Therapeutics (BTAI) PT Raised to $24 at Canaccord Genuity
-
Acadia Pharmaceuticals (ACAD) PT Lowered to $25 at Canaccord Genuity
-
Gildan Activewear (GIL) PT Raised to $36 at Canaccord Genuity
-
Canaccord Genuity Reiterates Buy Rating on Quixant PLC ()
-
Canaccord Genuity Reiterates Buy Rating on PrairieSky Royalty Ltd (PREKF)
-
Canaccord Genuity Reiterates Spec. Buy Rating on Petropavlovsk ()
-
Air Canada (AC:CN) (ACDVF) PT Raised to Cdn$50 at Canaccord Genuity
-
BioXcel Therapeutics (BTAI) PT Raised to $24 at Canaccord Genuity
-
Digital Turbine to Participate in Upcoming Investor Conferences

